Warner-lambert Company

Other

Pfizer Corporation

University of Texas System

University of Oklahoma

Charles Price Taylor, Jr

Graham Johnson

Christopher Franklin Bigge

Devin Franklin Welty

David Juergen Wustrow

Michael Francis Rafferty

Andrew John Thorpe

Lionel Bueno

Laurent Diop

Antonio Guglietta

Maria Chovet

William Patrick Watson

Hilary J Little

Jiayuan Ren

David James Dooley

Denis Schrier

Karin Nanette Westlund High

Christopher Peter Wayman

Mark Lawrence Weber

Pieter Hadewijn Van Der Graaf

W P Watson

Use of an alpha-2-delta ligand, or a pharmaceutically acceptable derivative thereof, for the manufacture of a medicament for the treatment of premature ejaculation.

Method of treatment for sexual dysfunction

This invention relates to a method of treating a disorder selected from OCD, agoraphobia, agoraphobia without history of panic disorder, specific phobia, social phobia, PTSD, restless legs syndrome, premenstrual dysphoric disorder, hot flashes, and fibromyalgia by administering a compound of the formula 1 or a pharmaceutically acceptable salt thereof, wherein: Ris hydrogen, straight or branched alkyl of from 1 to 6 carbon atoms or phenyl; and Ris straight or branched alkyl of from 4 to 8 carbon atoms, straight or branched alkenyl of from 2 to 8 carbon atoms, cycloalkyl of from 3 to 7 carbon atoms, alkoxy of from 1 to 6 carbon atoms, -alkylcycloalkyl, -alkylalkoxy, -alkyl OH, -alkylphenyl, -alkylphenoxy, or -substituted phenyl. The invention also relates to a method of treating the above disorders by administering the compound (3S,5R)-3-Aminomethyl-5-methyl-octanoic acid.

Alpha 2 delta ligands for post-traumatic stress disorder

This invention relates to a method of treating a disorder selected from OCD, agoraphobia, agoraphobia without history of panic disorder, specific phobia, social phobia, PTSD, restless legs syndrome, premenstrual dysphoric disorder, hot flashes, and fibromyalgia by administering a compound of the formula 1 or a pharmaceutically acceptable salt thereof, wherein:

Alpha2delta ligands for fibromyalgia and other disorders

GABA analogs such as gabapentin and pregabalin are useful to prevent and treat inflammatory diseases.

Anti-inflammatory method using gamma-aminobutyric acid (GABA) analogs

GABA analogs are useful to prevent and treat gastrointestinal damage and ethanol withdrawal syndrome. Preferred treatments employ gabapentin or pregabalin.

Method for preventing and treating alcoholism

Use of GABA analogs such as Gabapentin in the manufacture of a medicament for treating inflammatory diseases

Method for preventing and treating pain

The instant invention is novel uses of known N-(2,6-disubstituted phenyl)-N'-3- and 4-pyridinyl ureas and pharmaceutically acceptable acid addition salts thereof. Such compounds as N-(2-chloro-6-methylphenyl)-N'-4-pyridinyl urea monohydrochloride or N-(2,3-dichlorophenyl)-N'-4-pyridinyl urea are used for treating neurodegenerative disorders, perinatal asphyxia, Alzheimer's disease, Huntington's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis. The instant invention is similar novel uses of known anticonvulsant compounds as ralitoline, phenytoin, lamotrigine, tetrodotoxin, lidocaine, and carbamazepine.

Methods for treating neurodegenerative diseases and disorders using

GABA analogs to prevent and treat gastrointestinal damage

The present invention relates to a pharmaceutical composition containing a kainate excitatory amino acid antagonist and an uricosuric agent and to a method of treating neurodegenerative diseases using a combination of a kainate excitatory amino acid antagonist and an uricosuric agent.

Pharmaceutical composition and a method for treating neurodegenerative

The present invention is a pharmaceutical composition having a combination of an uricosuric agent such as probenecid or the like and an excitatory amino acid antagonist useful for treating a disease advantageously affected by treatment with an excitatory amino acid antagonist.

Method of treating neurodegenerative diseases using an AMPA excitatory

Pharmaceutical composition for and a method of using a combination of an

Growing community of inventors

Chelsea, MI, United States of America

Charles Price Taylor, Jr